Cvs health corporation (CVS)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09
Cash flows from operating activities:
Cash receipts from customers

253,271

248,393

238,763

219,350

202,023

186,519

175,814

176,228

176,050

176,594

176,820

176,329

174,741

172,310

169,175

162,264

155,866

148,954

144,914

140,488

136,471

132,406

125,401

121,479

117,480

114,993

114,150

112,007

112,016

113,205

109,276

107,382

103,924

97,688

98,854

96,708

94,556

94,503

93,304

93,816

94,302

93,568

0

0

0

Cash paid for inventory and prescriptions dispensed by retail network pharmacies

150,979

149,655

151,019

148,785

219,728

148,981

143,601

143,484

75,189

146,469

0

0

143,114

-

139,339

135,220

129,797

122,498

117,825

113,223

109,672

105,362

100,419

96,789

92,874

91,178

90,394

89,400

89,787

90,032

86,987

83,130

80,218

75,148

75,815

75,064

73,007

73,143

71,936

73,257

73,973

73,536

0

0

0

Insurance benefits paid

53,594

52,242

43,309

31,152

20,941

6,897

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for inventory and prescriptions dispensed by retail network pharmacies

150,979

149,655

151,019

148,785

219,728

148,981

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Insurance benefits paid

53,594

52,242

43,309

31,152

20,941

6,897

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid to other suppliers and employees

29,716

28,932

26,340

23,260

20,366

17,234

16,423

16,819

15,796

15,348

15,688

15,459

16,367

15,478

13,815

13,119

12,807

14,035

15,317

15,492

15,310

15,344

14,802

14,630

14,602

14,295

14,283

13,961

13,781

13,643

13,663

14,620

14,044

13,635

13,524

12,798

13,204

13,778

13,657

13,347

13,178

13,121

0

0

0

Interest received

911

955

994

962

844

644

412

205

65

21

21

21

21

20

20

21

23

21

19

18

15

15

14

12

10

8

7

5

4

4

3

3

4

4

4

4

4

4

4

4

4

5

0

0

0

Interest paid

2,959

2,954

3,719

3,745

3,381

2,803

1,962

1,093

1,289

1,072

1,055

1,064

1,090

1,140

1,160

933

920

629

612

627

630

647

623

598

534

534

539

567

557

581

604

630

625

647

598

597

578

583

571

542

574

542

0

0

0

Income taxes paid

2,729

2,717

2,677

2,508

2,489

2,383

2,780

2,726

2,799

2,909

2,906

2,832

2,956

3,060

3,163

3,409

3,371

3,274

2,915

3,075

2,925

2,931

3,319

3,164

3,165

3,211

2,965

2,888

2,370

2,282

2,264

2,205

2,265

2,406

2,111

2,113

2,186

2,224

2,335

2,250

2,257

2,339

0

0

0

Net cash provided by operating activities

14,205

12,848

12,693

10,862

8,458

8,865

6,250

7,764

6,829

8,007

10,264

11,587

11,235

10,141

11,718

9,604

8,994

8,539

8,264

8,089

7,949

8,137

6,252

6,310

6,315

5,783

5,976

5,196

5,525

6,671

5,761

6,800

6,776

5,856

6,810

6,140

5,585

4,779

4,809

4,424

4,324

4,035

0

0

0

Cash flows from investing activities:
Proceeds from sales and maturities of investments

6,351

7,049

6,390

4,566

2,793

817

83

82

63

61

36

40

49

91

204

270

277

243

157

98

122

161

255

239

191

136

0

0

0

-

-

-

-

-

-

-

-

1

0

0

0

-

-

-

-

Purchases of investments

7,022

7,534

6,606

4,701

2,706

692

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

2,483

2,457

2,475

2,414

2,271

2,037

1,958

1,942

1,943

1,918

2,029

2,010

2,083

2,224

2,484

2,527

2,546

2,367

2,190

2,187

2,167

2,136

2,090

2,071

2,054

1,984

2,046

2,016

1,972

2,030

2,018

1,980

1,939

1,872

1,794

1,849

1,913

2,005

2,175

2,323

2,483

2,548

0

0

0

Proceeds from sale-leaseback transactions

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

411

221

544

535

515

772

605

605

600

0

0

0

-

-

-

-

592

0

0

0

-

-

-

-

1,562

0

0

0

Acquisitions (net of cash acquired)

933

444

41,971

41,920

41,997

42,226

1,336

1,462

1,441

1,181

652

631

566

524

2,305

11,531

11,465

11,475

9,550

303

306

2,439

2,453

2,363

2,355

415

429

404

558

378

338

349

1,504

1,441

1,425

1,518

179

177

216

100

123

101

0

0

0

Proceeds from sale of subsidiary and other assets

-

-

-

-

-

832

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

0

0

0

-

-

-

-

-

0

0

0

-

0

0

0

Purchase of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

123

182

190

267

180

120

227

157

280

387

269

226

0

0

0

-

-

-

-

3

0

0

0

-

-

-

-

-

-

-

-

Other

-37

-42

-26

-28

-33

-21

-64

-53

-36

-33

-39

-35

-34

-37

29

32

29

35

31

18

14

11

49

50

54

54

36

34

28

23

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

Net cash used in investing activities

-4,045

-3,339

-44,529

-44,334

-44,045

-43,285

-2,696

-2,495

-2,471

-2,877

-2,385

-2,373

-2,374

-2,470

-4,072

-13,561

-13,509

-13,420

-11,511

-1,950

-2,029

-4,045

-3,747

-3,927

-3,828

-1,835

-2,288

-1,857

-1,973

-1,849

-1,030

-1,429

-2,554

-2,410

-2,815

-2,826

-1,542

-1,640

-1,412

-1,341

-1,021

-1,069

0

0

0

Cash flows from financing activities:
Net borrowings of short-term debt

-2,750

-720

1,070

445

3,005

-556

-110

-1,100

-1,768

-598

0

0

0

-

-

-

-

-685

-775

1,488

500

685

-39

0

-300

-690

-11

-200

300

-60

0

0

0

-

-

-

-

-15

284

524

-903

-2,729

0

0

0

Proceeds from issuance of long-term debt

7,682

3,736

8,425

4,967

4,967

44,343

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,800

0

0

0

Repayments of long-term debt

8,462

8,336

11,606

7,420

6,403

5,522

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,718

1,029

1,874

1,873

2,122

1,150

654

2,403

2,103

0

0

0

-

-

-

-

Purchase of noncontrolling interest in subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-39

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for (Proceeds from) Derivative Instrument, Financing Activities

-

-

-

-

-

-446

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of common stock

-

-

-

-

-

-

-

-

-

4,361

4,822

4,462

6,016

4,461

5,130

6,027

5,060

5,001

5,071

4,934

5,207

4,001

4,505

5,229

4,384

3,976

2,601

3,080

3,913

4,330

4,449

4,028

3,344

3,001

2,553

971

1,080

1,500

0

0

0

-

-

-

-

Dividends paid

2,606

2,603

2,462

2,326

2,179

2,038

2,038

2,039

2,041

2,049

1,995

1,939

1,886

1,840

1,775

1,711

1,647

1,576

1,502

1,435

1,362

1,288

1,239

1,191

1,145

1,097

1,031

962

895

829

793

753

714

674

627

579

528

479

468

459

451

439

0

0

0

Proceeds from exercise of stock options

263

210

211

223

236

242

229

270

315

329

333

292

313

296

362

344

340

362

320

366

393

421

447

457

504

500

590

627

708

836

767

685

602

431

455

404

295

285

185

304

292

250

0

0

0

Payments for taxes related to net share settlement of equity awards

84

112

143

140

137

97

40

48

64

71

70

203

95

72

3

-105

-8

63

149

138

128

106

103

93

86

62

55

54

41

28

0

0

0

-

-

-

-

28

6

27

29

19

0

0

0

Other

-9

0

12

8

6

1

0

0

0

-

-

-

-

-5

-7

-7

-7

-3

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-5,991

-7,850

-4,518

-4,243

-505

36,819

35,597

36,504

35,522

-6,751

-7,542

-8,207

-8,407

-6,761

-8,337

3,857

4,798

4,879

5,015

-6,503

-7,165

-5,694

-2,872

-1,947

-1,275

-1,237

-3,421

-3,986

-4,212

-4,860

-5,205

-5,776

-4,173

-3,460

-3,267

-2,193

-2,928

-2,798

-3,548

-3,201

-3,253

-3,232

0

0

0

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-10

-17

-22

-20

-10

-4

-3

-6

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in cash, cash equivalents and restricted cash

4,169

1,659

-36,358

-37,719

-36,096

2,395

39,152

41,774

39,881

-1,620

337

1,007

455

912

-701

-117

261

-22

1,758

-368

-1,248

-1,608

-373

438

1,215

2,714

272

-649

-660

-38

-474

-405

49

-14

728

1,121

1,115

341

-151

-118

50

-266

0

0

0

Reconciliation of net income to net cash provided by operating activities:
Reconciliation of net income (loss) to net cash provided by operating activities:
Net income

7,216

6,631

4,466

4,327

-167

-596

3,112

3,007

6,668

6,623

5,043

5,299

5,125

5,319

5,111

4,817

5,165

5,239

5,061

4,762

4,736

4,644

4,588

4,889

4,767

4,592

4,443

4,200

4,041

3,862

3,810

3,671

3,521

3,458

3,419

3,360

3,366

3,424

3,449

3,662

3,728

3,696

0

0

0

Adjustments required to reconcile net income to net cash provided by operating activities:
Adjustments required to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization

4,346

4,371

4,082

3,610

3,185

2,718

2,533

2,528

2,504

2,479

2,485

2,481

2,477

2,475

2,429

2,350

2,219

2,092

1,999

1,944

1,944

1,931

1,900

1,884

1,845

1,870

1,868

1,850

1,832

1,753

1,693

1,657

1,617

1,568

1,545

1,508

1,485

1,469

1,448

1,379

1,393

1,389

0

0

0

Stock-based compensation

435

453

463

396

339

280

233

236

234

234

229

223

220

222

221

249

243

230

219

176

174

165

161

152

142

141

136

134

130

132

132

134

135

135

138

140

149

150

164

165

180

165

0

0

0

Deferred income taxes and other noncash items

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

-218

-

-178

-96

-105

-58

-279

-124

-136

-86

-69

-112

-66

-111

97

98

95

144

121

179

98

30

22

-33

16

48

0

0

0

Change in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable, net

2,884

2,158

1,726

761

3,985

1,139

2,386

1,886

132

941

-1,191

-922

-936

243

778

1,662

2,244

1,594

1,395

1,364

1,079

737

2,564

2,219

2,236

2,210

1,609

949

430

387

565

289

395

748

293

296

199

-532

-581

-406

-196

86

0

0

0

Inventories

1,535

1,075

1,212

583

-312

1,153

662

637

1,434

514

-215

83

375

742

585

843

739

1,141

1,214

1,000

1,019

770

358

415

238

-12

346

134

-109

853

316

525

704

-586

-206

-278

-94

352

609

990

1,224

1,199

0

0

0

Other current assets

-

-

-

-

-

-

-

-

-

-

222

-131

188

8

234

-54

-192

-355

-368

178

184

383

231

134

63

-105

246

86

45

-3

-178

2

104

420

136

137

-5

4

-19

-48

-74

-48

0

0

0

Other assets

1,344

614

374

143

449

3

326

474

280

338

0

0

-8

-

71

3

-2

-2

-15

16

4

-9

29

20

39

135

82

56

45

99

139

168

186

49

0

0

0

-

-

-

-

2

0

0

0

Accounts payable and pharmacy claims and discounts payable

5,500

3,550

2,820

2,201

2,485

2,329

3,219

2,575

2,071

1,710

949

1,205

852

2,189

2,366

2,615

2,876

2,834

2,558

2,604

2,159

1,742

1,549

1,447

1,593

1,024

925

590

-127

1,147

1,331

1,061

1,637

1,128

788

968

610

-40

-348

-230

4

4

0

0

0

Health care costs payable and other insurance liabilities

-94

320

224

-39

6

-311

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

0

0

1,211

-

2,518

1,688

1,507

892

907

786

851

1,060

1,071

905

719

471

517

-730

-370

766

-550

1,146

1,199

105

1,371

495

315

-176

161

61

-131

-66

0

0

0

Other liabilities

2,859

1,476

1,346

-506

-834

165

-726

401

501

-333

174

288

283

152

61

-6

-9

-104

-76

-50

-45

13

-77

-55

-39

-1

91

141

148

110

143

70

14

2

-76

-87

-76

-44

-94

-41

66

38

0

0

0